BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14597591)

  • 1. Hospitalization costs of primary stenting versus thrombolysis in acute myocardial infarction: cost analysis of the Canadian STAT Study.
    Le May MR; Davies RF; Labinaz M; Sherrard H; Marquis JF; Laramée LA; O'Brien ER; Williams WL; Beanlands RS; Nichol G; Higginson LA
    Circulation; 2003 Nov; 108(21):2624-30. PubMed ID: 14597591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of acute myocardial infarction in Switzerland: is emergency PTCA more costly than thrombolysis?].
    Hagmann A; Amann W; Urban P; Pfisterer M
    Schweiz Med Wochenschr; 1999 Oct; 129(39):1389-96. PubMed ID: 10542996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
    Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
    Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stenting versus thrombolysis in acute myocardial infarction trial (STAT).
    Le May MR; Labinaz M; Davies RF; Marquis JF; Laramée LA; O'Brien ER; Williams WL; Beanlands RS; Nichol G; Higginson LA
    J Am Coll Cardiol; 2001 Mar; 37(4):985-91. PubMed ID: 11263625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary angioplasty is cost-minimizing compared with pre-hospital thrombolysis for patients within 60 min of a percutaneous coronary intervention center: the Comparison of Angioplasty and Pre-hospital Thrombolysis in Acute Myocardial Infarction (CAPTIM) cost-efficacy sub-study.
    Machecourt J; Bonnefoy E; Vanzetto G; Motreff P; Marlière S; Leizorovicz A; Allenet B; Lacroute JM; Cassagnes J; Touboul P
    J Am Coll Cardiol; 2005 Feb; 45(4):515-24. PubMed ID: 15708697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the cost of a systematic early reperfusion of the infarction artery by primary or salvage angioplasty].
    Himbert D; Simon-Lorière Y; Juliard JM; Steg PG; Aumont MC; Gourgon R
    Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):569-76. PubMed ID: 9538368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of the cost effectiveness of treatment of acute myocardial infarct with primary angioplasty and thrombolysis ].
    Golán L; Simek S; Linhart A; Cahlík T; Palecek T; Lubanda JC; Korínek J; Beran S; Aschermann M
    Vnitr Lek; 2003 Feb; 49(2):97-102. PubMed ID: 12728575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary PTCA versus thrombolysis with tPA in acute myocardial infarction: a formal cost-effectiveness analysis.
    Müllner M; Paulis M; Nikfardjam M; Domanovits H; Huber K
    Wien Klin Wochenschr; 1999 Jan; 111(1):37-41. PubMed ID: 10067269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarction.
    Rocha-Singh KJ; McShane KJ; Ligon R; Sung CH
    Catheter Cardiovasc Interv; 2000 Feb; 49(2):135-41. PubMed ID: 10642759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What aspects are inefficient concerning percutaneous coronary intervention in Japan?: International cost-effectiveness comparisons].
    Chino M; Sakamoto M; Sasaki T; Isshiki T
    J Cardiol; 2004 Sep; 44(3):85-92. PubMed ID: 15500158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
    Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
    Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.
    Kastrati A; Mehilli J; Nekolla S; Bollwein H; Martinoff S; Pache J; Schühlen H; Seyfarth M; Gawaz M; Neumann FJ; Dirschinger J; Schwaiger M; Schömig A;
    J Am Coll Cardiol; 2004 Mar; 43(5):734-41. PubMed ID: 14998609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
    Chen JC; Kaul P; Levy JH; Haverich A; Menasché P; Smith PK; Carrier M; Verrier ED; Van de Werf F; Burge R; Finnegan P; Mark DB; Shernan SK;
    Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
    Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency department physician activation of the catheterization laboratory and immediate transfer to an immediately available catheterization laboratory reduce door-to-balloon time in ST-elevation myocardial infarction.
    Khot UN; Johnson ML; Ramsey C; Khot MB; Todd R; Shaikh SR; Berg WJ
    Circulation; 2007 Jul; 116(1):67-76. PubMed ID: 17562960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational economic evaluation of valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).
    Reed SD; Friedman JY; Velazquez EJ; Gnanasakthy A; Califf RM; Schulman KA
    Am Heart J; 2004 Jul; 148(1):122-8. PubMed ID: 15215801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.